Bottom Line Semaglutide has a growing body of clinical evidence behind it, and for many people managing weight, type 2 diabetes, or cardiovascular risk, the long-term benefits can outweigh the risks
Semaglutide activates one incretin receptor (GLP-1)
Nonclinical Toxicology 13.1 Carcinogenesis, Mutagenesis, Impairment of Fertility In a 2-year carcinogenicity study in CD-1 mice, subcutaneous doses of 0.3, 1 and 3 mg/kg/day [9-, 33- and 113- fold the maximum recommended human dose (MRHD) of RYBELSUS 14 mg, based on AUC] were administered to the males, and 0.1, 0.3 and 1 mg/kg/day (3-, 9- and 33-fold MRHD) were administered to the females
Can you tell us what happened
Adequate nutrition is essential for reproductive health, and deficiencies in key nutrients (iron, folate, vitamin D, zinc) can impact fertility
semaglutide users who received higher dosage formulations increased at each subsequent timepoint post-index